PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression

Drug Metabolism and Disposition

Volumn 34, Issue 11, 2006, Pages 1927-1934

  Watanabe, Chizuru ^a   Kato, Yukio ^a   Sugiura, Tomoko ^a   Kubo, Yoshiyuki ^a   Wakayama, Tomohiko ^a   Iseki, Shoichi ^a   Tsuji, Akira ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CARNITINE; N METHYLNICOTINAMIDE; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PDZ PROTEIN; PDZK2 PROTEIN; PROCAINAMIDE; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VERAPAMIL;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL KINETICS; CELL SURFACE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BIOLOGICAL TRANSPORT; CARNITINE; CELL LINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MICE; ORGANIC CATION TRANSPORT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 33751078077     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.010207     Document Type: Article

References (40)

1. Anzai N, Miyazaki H, Noshiro R, Khamdang S, Chairoungdua A, Shin HJ, Enomoto A, Sakamoto S, Hirata T, Tomita K, et al. (2004) The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem 279:45942-45950.
2. Bezprozvanny I and Maximov A (2001) Classification of PDZ domains. FEBS Lett 509:457-642.
3. Biber J, Gisler SM, Hernando N, Wagner CA, and Murer H (2004) PDZ interactions and proximal tubular phosphate reabsorption. Am J Physiol 287:F871-F875.
4. Brone B and Eggermont J (2005) PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am J Physiol 288:C20-C29.
5. Custer M, Spindler B, Verrey F, Murer H, and Biber J (1997) Identification of a new gene product (diphor-1) regulated by dietary phosphate. Am J Physiol 273:F801-F806.
6. Gisler SM, Pribanic S, Bacic D, Forrer P, Gantenbein A, Sabourin LA, Tsuji A, Zhao Z, Manser E, Biber J, et al. (2003) PDZK1. I. A major scaffolder in brush borders of proximal tubular cells. Kidney Int 64:1733-1745.
7. Gisler SM, Stagljar I, Traebert M, Bacic D, Biber J, and Murer H (2001) Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J Biol Chem 276:9206-9213.
8. Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, and Schomig E (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 102:5256-5261.
9. Harris BZ and Lim WA (2001) Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 114:3219-3231.
10. Hegedus T, Sessler T, Scott R, Thelin W, Bakos E, Varadi A, Szabo K, Homolya L, Milgram SL, and Sarkadi B (2003) C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. Biochem Biophys Res Commun 302:454-461.
11. Hillier BJ, Christopherson KS, Prehoda KE, Bredt DS, and Lim WA (1999) Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science (Wash DC) 284:812-815.
12. Imaoka T, Kusuhara H, Adachi-Akahane S, Hasegawa M, Morita N, Endou H, and Sugiyama Y (2004) The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. J Am Soc Nephrol 15:2012-2022.
13. Jonker JW and Schinkel AH (2004) Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308:2-9.
14. Karthikeyan S, Leung T, and Ladias JA (2001) Structural basis of the Na+/H+ exchanger regulatory factor PDZ1 interaction with the carboxyl-terminal region of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 276:19683-19686.
15. Kato Y, Sai Y, Yoshida K, Watanabe C, Hirata T, and Tsuji A (2005) PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol Pharmacol 67:734-743.
16. Kato Y, Yoshida K, Watanabe C, Sai Y, and Tsuji A (2004) Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm Res (NY) 21:1886-1894.
17. Kocher O, Comella N, Gilchrist A, Pal R, Tognazzi K, Brown LF, and Knoll JH (1999) PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. Lab Investig 79:1161-1170.
18. Koepsell H and Endou H (2004) The SLC22 drug transporter family. Pflueg Arch Eur J Physiol 447:666-676.
19. Koepsell H, Schmitt BM, and Gorboulev V (2003) Organic cation transporters. Rev Physiol Biochem Pharmacol 150:36-90.
20. Lee W and Kim RB (2004) Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol 44:137-166.
21. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
22. Ohashi R, Tamai I, Inano A, Katsura M, Sai Y, Nezu J, and Tsuji A (2002) Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein. J Pharmacol Exp Ther 302:1286-1294.
23. Ohashi R, Tamai I, Nezu J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, and Tsuji A (2001) Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 59:358-366.
24. Ohashi R, Tamai I, Yabuuchi H, Nezu J, Oku A, Sai Y, Shimane M, and Tsuji A (1999) Na(+)-dependent carnitine transport by organic cation transporter (OCTN2), its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291:778-784.
25. Russel FG, Masereeuw R, and van Aubel RA (2002) Molecular aspects of renal anionic drug transport. Annu Rev Physiol 64:563-594.
26. Sai Y and Tsuji A (2004) Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov Today 9:712-720.
27. Scott RO, Thelin WR, and Milgram SL (2002) A novel PDZ protein regulates the activity of guanylyl cyclase C, the heat-stable enterotoxin receptor. J Biol Chem 277:22934-22941.
28. Tamai I, China K, Sai Y, Kobayashi D, Nezu J, Kawahara E, and Tsuji A (2001) Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 1512:273-284.
29. Tamai I, Nakanishi T, Kobayashi D, China K, Kosugi Y, Nezu J, Sai Y, and Tsuji A (2004) Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol Pharm 1:57-66.
30. Tamai I, Ohashi R, Nezu J, Sai Y, Kobayashi D, Oku A, Shimane M, and Tsuji A (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072.
31. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, and Tsuji A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382.
32. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, and Tsuji A (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111.
33. Wang P, Wang JJ, Xiao Y, Murray JW, Novikoff PM, Angeletti RH, Orr GA, Lan D, Silver DL, and Wolkoff AW (2005) Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 (OATP1A1) on the hepatocyte surface. J Biol Chem 280:30143-30149.
34. Wang S, Yue H, Derin RB, Guggino WB, and Li M (2000) Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 103:169-179.
35. Wang Y, Ye J, Ganapathy V, and Longo N (1999) Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci USA 96:2356-2360.
36. + exchanger requires a dissociable phosphoprotein cofactor. J Clin Investig 92:1781-1786.
37. Wright SH (2005) Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics. Toxicol Appl Pharmacol 204:309-319.
38. Wu X, Prasad PD, Leibach FH, and Ganapathy V (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-595.
39. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, and Tsuji A (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289:768-773.
40. Yun CH, Oh S, Zizak M, Steplock D, Tsao S, Tse CM, Weinman EJ, and Donowitz M (1997) cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci USA 94:3010-3015.